195 related articles for article (PubMed ID: 32266326)
1. Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study.
Hudesman DP; Chakravarty SD; Emond B; Ellis LA; Lefebvre P; Sadik K; Scher JU
BMC Rheumatol; 2020; 4():16. PubMed ID: 32266326
[TBL] [Abstract][Full Text] [Related]
2. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
[TBL] [Abstract][Full Text] [Related]
3. Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.
Emond B; Ellis LA; Chakravarty SD; Ladouceur M; Lefebvre P
Curr Med Res Opin; 2019 Oct; 35(10):1751-1759. PubMed ID: 31106607
[No Abstract] [Full Text] [Related]
4. Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 to 2020.
Merola JF; Dennis N; Chakravarty SD; Villacorta R; Mesana L; Lin I; Wang Y; Shawi M; Pacou M; Baker T; Peterson S
Clin Rheumatol; 2021 Oct; 40(10):4061-4070. PubMed ID: 33934270
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
6. Economic Burden of Fatigue in Inflammatory Bowel Disease.
Ananthakrishnan AN; Desai R; Lee WJ; Griffith J; Chen N; Loftus EV
Crohns Colitis 360; 2023 Jul; 5(3):otad020. PubMed ID: 37663925
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
Merola JF; Patil D; Egana A; Steffens A; Webb NS; Gottlieb AB
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2635-2648. PubMed ID: 37726542
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population.
Lee S; Xie L; Wang Y; Vaidya N; Baser O
J Med Econ; 2018 Jun; 21(6):564-570. PubMed ID: 29359606
[TBL] [Abstract][Full Text] [Related]
9. Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
Schreiber S; Colombel JF; Feagan BG; Reich K; Deodhar AA; McInnes IB; Porter B; Das Gupta A; Pricop L; Fox T
Ann Rheum Dis; 2019 Apr; 78(4):473-479. PubMed ID: 30674475
[TBL] [Abstract][Full Text] [Related]
10. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis.
Feldman SR; Zhao Y; Shi L; Tran MH; Lu J
Arthritis Care Res (Hoboken); 2015 May; 67(5):708-17. PubMed ID: 25303478
[TBL] [Abstract][Full Text] [Related]
11. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.
Merola JF; Herrera V; Palmer JB
Clin Rheumatol; 2018 Oct; 37(10):2751-2761. PubMed ID: 30051284
[TBL] [Abstract][Full Text] [Related]
12. Burden of Herpes Zoster Among Patients with Psoriasis in the United States.
Singer D; Thompson-Leduc P; Ma S; Gupta D; Cheng WY; Sendhil SR; Sundar M; Hagopian E; Stempniewicz N; Duh MS; Poston S
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2649-2668. PubMed ID: 37740149
[TBL] [Abstract][Full Text] [Related]
13. Abdominal pain is associated with an increased risk of future healthcare resource utilization in inflammatory bowel disease.
Zubrzycka I; Bogale K; Stuart A; Cesaire M; Walter V; Dalessio S; Tinsley A; Williams E; Clarke K; Coates MD
Int J Colorectal Dis; 2023 Aug; 38(1):213. PubMed ID: 37578543
[TBL] [Abstract][Full Text] [Related]
14. Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.
Penso L; Bergqvist C; Meyer A; Herlemont P; Weill A; Zureik M; Dray-Spira R; Sbidian E
Arthritis Rheumatol; 2022 Feb; 74(2):244-252. PubMed ID: 34279061
[TBL] [Abstract][Full Text] [Related]
15. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis.
Skornicki M; Prince P; Suruki R; Lee E; Louder A
Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686
[TBL] [Abstract][Full Text] [Related]
16. A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients.
Chastek B; White J; Van Voorhis D; Tang D; Stolshek BS
Adv Ther; 2016 Apr; 33(4):626-42. PubMed ID: 26970958
[TBL] [Abstract][Full Text] [Related]
17. Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease.
Szigethy EM; Murphy SM; Ehrlich OG; Heller CA; Engel-Nitz NM; Meadows P; Allen JI
Crohns Colitis 360; 2021 Apr; 3(2):otab021. PubMed ID: 36778940
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn's Disease.
Perera S; Yang S; Stott-Miller M; Brady J
J Health Econ Outcomes Res; 2018; 6(1):96-112. PubMed ID: 32685575
[TBL] [Abstract][Full Text] [Related]
19. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
[TBL] [Abstract][Full Text] [Related]
20. Mental Health Costs of Inflammatory Bowel Diseases.
Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
